Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("AUDIA, J. E")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

Indolyl participation in the Mitsunobu reaction : retention of stereochemistryAUDIA, J. E; COLOCCI, N.Tetrahedron letters. 1991, Vol 32, Num 31, pp 3779-3782, issn 0040-4039Article

Acyclic stereocontrol in catalyzed intramolecular Diels-Alder cyclizations leading to octahydronaphthalenecarboxaldehydesMARSHALL, J. A; GROTE, J; AUDIA, J. E et al.Journal of the American Chemical Society. 1987, Vol 109, Num 4, pp 1186-1194, issn 0002-7863Article

An application of the Ireland reaction to the stereospecific synthesis of fused carbocyclic systemsDANISHEFSKY, S. J; AUDIA, J. E.Tetrahedron letters. 1988, Vol 29, Num 12, pp 1371-1374, issn 0040-4039Article

Acyclic stereocontrol in catalyzed intramolecular Diels―Alder cyclizations of 4-methyl-2,8,10-undecatrienalsMARSHALL, J. A; AUDIA, J. E; GROTE, J et al.Journal of organic chemistry. 1986, Vol 51, Num 7, pp 1155-1157, issn 0022-3263Article

Intramolecular Diels-Alder cyclization of conjugated aldehydes: synthesis of a chlorothricolide intermediateMARSHALL, J. A; AUDIA, J. E; GROTE, J et al.Journal of organic chemistry. 1984, Vol 49, Num 26, pp 5277-5279, issn 0022-3263Article

Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor : strucutally specific differentiation by ergolines and tryptaminesNELSON, D. L; LUCAITES, V. L; AUDIA, J. E et al.The Journal of pharmacology and experimental therapeutics. 1993, Vol 265, Num 3, pp 1272-1279, issn 0022-3565Article

Conjugate addition of organocuprates to trans-4a,5,6,7,8,8a-hexahydronaphthalene-1-carboxaldehydes: synthesis of a chlorothricin degradation productMARSHALL, J. A; AUDIA, J. E; SHEARER, B. G et al.Journal of organic chemistry. 1986, Vol 51, Num 10, pp 1730-1735, issn 0022-3263Article

Synthesis of the individual enantiomers of the benzoquinolinone human type 1 steroid 5-α-reductase inhibitors LY191704 and LY266111AUDIA, J. E; LAWHORN, D. E; DEETER, J. B et al.Tetrahedron letters. 1993, Vol 34, Num 44, issn 0040-4039, 6959, 7001-7004 [5 p.]Article

Kinetic analysis of LY320236 : competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductaseMCNULTY, A. M; AUDIA, J. E; BEMIS, K. G et al.Journal of steroid biochemistry and molecular biology. 2000, Vol 72, Num 1-2, pp 13-21, issn 0960-0760Article

Synthesis and 5α-reductase inhibitory activity of 8-substituted benzo[f]quinolinones derived from palladium mediated coupling reactionsSMITH, E. C. R; MCQUAID, L. A; GOODE, R. L et al.Bioorganic & medicinal chemistry letters (Print). 1998, Vol 8, Num 4, pp 395-398, issn 0960-894XArticle

LY191704 : a selective, nonsteroidal inhibitor of human steroid 5α-reductase type 1HIRSCH, K. S; JONES, C. D; AUDIA, J. E et al.Proceedings of the National Academy of Sciences of the United States of America. 1993, Vol 90, Num 11, pp 5277-5281, issn 0027-8424Article

Diels-Alder cyclization of 2,8,10-undecatrienals as a route to 1,2,3,4,4a,5,6,8a-octahydronaphthalenesMARSHALL, J. A; AUDIA, J. E; GROTE, J et al.Tetrahedron (Oxford. Print). 1986, Vol 42, Num 11, pp 2893-2902, issn 0040-4020Article

Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5α-reductase inhibitorSUTKOWSKI, D. M; AUDIA, J. E; GOODE, R. L et al.The Prostate. 1996, pp 62-66, issn 0270-4137, SUP6Conference Paper

N(1-)-substituted ergolines and tryptamines show species differences for the agonist-labeled 5-HT2 receptorJOHNSON, M. P; AUDIA, J. E; NISSEN, J. S et al.European journal of pharmacology. 1993, Vol 239, Num 1-3, pp 111-118, issn 0014-2999Article

Synthesis of two useful, enenatiomerically pure derivatives of (S)-4-hydroxy-2-cyclohexenoneAUDIA, J. E; BOISVERT, L; PATTEN, A. D et al.Journal of organic chemistry. 1989, Vol 54, Num 15, pp 3738-3740, issn 0022-3263, 3 p.Article

N-methyl-5-tert-butyltryptamine : A novel, highly potent 5-HT1D receptor agonistXU, Y.-C; SCHAUS, J. M; WALKER, C et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 3, pp 526-531, issn 0022-2623Article

Characterization of type I 5α-reductase activity in DU145 human prostatic adenocarcinoma cellsKAEFER, M; AUDIA, J. E; NEUBAUER, B. L et al.Journal of steroid biochemistry and molecular biology. 1996, Vol 58, Num 2, pp 195-205, issn 0960-0760Article

Stereoselective epoxidations and electrophilic additions to partial ergot alkaloids and conformationally-fixed styrenes. Experimental and theoretical modeling evidence for the importance of torsional steering as a stereocontrol elementMARTINELLI, M. J; PETERSON, B. C; KHAU, V. V et al.Journal of organic chemistry. 1994, Vol 59, Num 8, pp 2204-2210, issn 0022-3263Article

Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptorWAINSCOTT, D. B; COHEN, M. L; SCHENCK, K. W et al.Molecular pharmacology. 1993, Vol 43, Num 3, pp 419-426, issn 0026-895XArticle

  • Page / 1